BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tapper EB, Konerman M, Murphy S, Sonnenday CJ. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant 2018;18:2566-70. [PMID: 30019835 DOI: 10.1111/ajt.15020] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Holman A, Parikh N, Clauw DJ, Williams DA, Tapper EB. Contemporary management of pain in cirrhosis: Toward precision therapy for pain. Hepatology 2023;77:290-304. [PMID: 35665522 DOI: 10.1002/hep.32598] [Reference Citation Analysis]
2 Kao J, Reid N, Hubbard RE, Homes R, Hanjani LS, Pearson E, Logan B, King S, Fox S, Gordon EH. Frailty and solid-organ transplant candidates: a scoping review. BMC Geriatr 2022;22:864. [DOI: 10.1186/s12877-022-03485-7] [Reference Citation Analysis]
3 Tapper EB, Essien UR, Zhao Z, Ufere NN, Parikh ND. Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United States. J Hepatol 2022;77:377-82. [PMID: 35367057 DOI: 10.1016/j.jhep.2022.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ge J, Kim WR, Lai JC, Kwong AJ. "Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. J Hepatol 2022;76:1318-29. [PMID: 35589253 DOI: 10.1016/j.jhep.2022.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Li C, Zhao C, Yu Z, Yang W, Sun M, Li Y, Guo G, Hui Y, Wang X, Fan X, Wang B, Zhang J, Sun C. Low free triiodothyronine levels are associated with frail phenotype in hospitalized inpatients with cirrhosis. Postgrad Med 2022. [PMID: 35382681 DOI: 10.1080/00325481.2022.2063487] [Reference Citation Analysis]
6 Tapper EB, Kenney B, Nikirk S, Levine DA, Waljee AK. Animal Naming Test Is Associated With Poor Patient-Reported Outcomes and Frailty in People With and Without Cirrhosis: A Prospective Cohort Study. Clin Transl Gastroenterol 2022. [PMID: 35080516 DOI: 10.14309/ctg.0000000000000447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ohikere K, Veracruz N, Wong RJ. Cognitive Impairment and Cirrhosis in Older Patients: A Systematic Review. Gerontol Geriatr Med 2022;8:23337214221122520. [PMID: 36105374 DOI: 10.1177/23337214221122520] [Reference Citation Analysis]
8 Singh S, Taneja S, Tandon P, Bansal A, Gorsi U, Roy A, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis. J Clin Exp Hepatol 2022;12:398-408. [PMID: 35535083 DOI: 10.1016/j.jceh.2021.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Peng Y, Wei Q, Liu Y, Wu Z, Zhang H, Wu H, Chai J. Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy. Gastroenterol Res Pract 2021;2021:5623601. [PMID: 34712321 DOI: 10.1155/2021/5623601] [Reference Citation Analysis]
10 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;56:1210-9. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Louissaint J, Murphy SL, Sonnenday CJ, Lok AS, Tapper EB. Applying Administrative Data-Based Coding Algorithms for Frailty in Patients With Cirrhosis. Liver Transpl 2021;27:1401-11. [PMID: 33871175 DOI: 10.1002/lt.26078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 39.5] [Reference Citation Analysis]
13 Mehta M, Louissaint J, Parikh NS, Long MT, Tapper EB. Cognitive Function, Sarcopenia, and Inflammation Are Strongly Associated with Frailty: A Framingham Cohort Study. Am J Med 2021:S0002-9343(21)00497-6. [PMID: 34464599 DOI: 10.1016/j.amjmed.2021.07.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Berry K, Duarte-Rojo A, Grab JD, Dunn MA, Boyarsky BJ, Verna EC, Kappus MR, Volk ML, McAdams-DeMarco M, Segev DL, Ganger DR, Ladner DP, Shui A, Tincopa MA, Rahimi RS, Lai JC; from the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Cognitive Impairment and Physical Frailty in Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34558844 DOI: 10.1002/hep4.1796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Feng H, Wang X, Mao L, Yu Z, Cui B, Lin L, Hui Y, Zhao X, Xu X, Fan X, Wang B, Yu Q, Jiang K, Sun C. Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis. Ther Adv Chronic Dis 2021;12:20406223211026996. [PMID: 34377386 DOI: 10.1177/20406223211026996] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Saleh ZM, Solano QP, Louissaint J, Jepsen P, Tapper EB. The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis. United European Gastroenterol J 2021;9:672-80. [PMID: 34102040 DOI: 10.1002/ueg2.12104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Skladany L, Molcan P, Vnencakova J, Vrbova P, Kukla M, Laffers L, Koller T. Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis. Can J Gastroenterol Hepatol 2021;2021:5576531. [PMID: 34095016 DOI: 10.1155/2021/5576531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Acharya C, White MB, Fagan A, Sterling RK, Stravitz RT, Puri P, Fuchs M, Luketic V, Sanyal AJ, Wade JB, Gilles H, Heuman DM, Tinsley F, Matherly S, Lee H, Siddiqui MS, Thacker LR, Bajaj JS. Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls. Dig Dis Sci 2021;66:1360-6. [PMID: 32323075 DOI: 10.1007/s10620-020-06261-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Williams FR, Milliken D, Lai JC, Armstrong MJ. Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun 2021;5:923-37. [PMID: 34141980 DOI: 10.1002/hep4.1688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
20 Shah S, Goldberg DS, Kaplan DE, Sundaram V, Taddei TH, Mahmud N. Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute-on-Chronic Liver Failure. Liver Transpl 2021;27:16-26. [PMID: 32946660 DOI: 10.1002/lt.25896] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
21 Murphy SL, Richardson JK, Blackwood J, Martinez B, Tapper EB. Neurocognitive and Muscular Capacities Are Associated with Frailty in Adults with Cirrhosis. Dig Dis Sci 2020;65:3734-43. [PMID: 31982996 DOI: 10.1007/s10620-020-06099-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
22 San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, Urios A, Mestre-Salvador V, Correa-Ghisays P, Ballester MP, Escudero-García D, Tosca J, Montón C, Ríos MP, Kosenko E, Felipo V, Tabares-Seisdedos R, Selva-Vera G, Montoliu C. Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy. J Clin Med 2020;9:E2154. [PMID: 32650464 DOI: 10.3390/jcm9072154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Foster C, Baki J, Nikirk S, Williams S, Parikh ND, Tapper EB. Comprehensive Health-State Utilities in Contemporary Patients With Cirrhosis. Hepatol Commun 2020;4:852-8. [PMID: 32490321 DOI: 10.1002/hep4.1512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Salim T, Stark SA, Duarte-rojo A. Food as Therapy for Frailty. Curr Hepatology Rep 2020;19:23-9. [DOI: 10.1007/s11901-020-00509-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Tapper EB. Deciphering the Cirrhotic Patient’s Present Status: The Overlap Between Physical Frailty, Disability, and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_3] [Reference Citation Analysis]
26 Hey P, Sinclair M. Upcoming Pharmacological and Interventional Therapies for the Treatment of Physical Frailty and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_15] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Hassan A, Tapper EB. Frailty and Sarcopenia in the Critically Ill Patient with Cirrhosis. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_9] [Reference Citation Analysis]
28 Bémeur C, Rose CF. Hepatic Encephalopathy, Sarcopenia, and Frailty. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_17] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Fallahzadeh MA, Rahimi RS. Hepatic Encephalopathy and Nutrition Influences: A Narrative Review. Nutr Clin Pract 2020;35:36-48. [PMID: 31872484 DOI: 10.1002/ncp.10458] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
30 Tapper EB, Derstine B, Baki J, Su GL. Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis. Dig Dis Sci 2019;64:3652-9. [PMID: 31292783 DOI: 10.1007/s10620-019-05713-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
31 Hanai T, Shiraki M, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis. Hepatol Res 2019;49:1414-26. [PMID: 31408558 DOI: 10.1111/hepr.13420] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
32 Van Jacobs AC. Frailty Assessment in Patients with Liver Cirrhosis. Clin Liver Dis (Hoboken) 2019;14:121-5. [PMID: 31632663 DOI: 10.1002/cld.825] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
33 Tapper EB. Predicting Overt Hepatic Encephalopathy for the Population With Cirrhosis. Hepatology 2019;70:403-9. [PMID: 30703852 DOI: 10.1002/hep.30533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
34 Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, Carey EJ, Dasarathy S, Kamath BM, Kappus MR, Montano-Loza AJ, Nagai S, Tandon P. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant 2019;19:1896-906. [PMID: 30980701 DOI: 10.1111/ajt.15392] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 16.5] [Reference Citation Analysis]
35 Alsahhar JS, Rahimi RS. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy. Curr Opin Gastroenterol 2019;35:145-54. [PMID: 30893082 DOI: 10.1097/MOG.0000000000000527] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
36 Johansen KL. Metrics of Aging in Transplantation. Curr Transpl Rep 2019;6:36-44. [DOI: 10.1007/s40472-019-0229-x] [Reference Citation Analysis]
37 Tapper EB. Frailty and Outcomes After Liver Transplantation. Curr Transplant Rep 2019;6:1-6. [PMID: 31602355 DOI: 10.1007/s40472-019-0222-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]